Lantheus Holdings (NASDAQ: LNTH) reported Q2 EPS of $0.24, $0.18 better than the analyst estimate of $0.06. Revenue for the quarter came in at $78 million versus the consensus estimate of $72.66 million.

Mary Anne Heino, President and CEO commented, “We are very pleased with our second quarter results, which delivered 6% year over year growth and exceeded both our second quarter revenue and Adjusted EBITDA guidance. During the second quarter, we saw continued strong performance of DEFINITY with 18% year over year growth in a competitive ultrasound contrast market and higher than forecasted sales of our nuclear products, demonstrating that our commercial strategy is working.”

Ms. Heino continued, “We are also very pleased to be raising our annual revenue and Adjusted EBITDA guidance which reflects the overall strength of our product portfolio and the firm contracts we have with key nuclear products customers.”

GUIDANCE:

Lantheus Holdings sees FY2016 revenue of $291-295 million, versus the consensus of $290.8 million.

For earnings history and earnings-related data on Lantheus Holdings (LNTH) click here.